
Alternatives
Mubadala and Others Pledge Big Money for UK-Based AI Drug Discovery Firm
Exscientia has just closed a $225 million Series D funding round, enlisting giant institutional investors.
Two major US private foundations lead venture capital push into AI, which they say will disrupt multiple industries.
Tech has low adoption, but Fidelity’s CIO says it’s ‘still early days.’
World’s largest pension fund CIO explains reasons for Sony Computer Science research partnership.